• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Natural surfactant preparation in complex therapy of acute respiratory distress syndrome in adults following open-heart surgeries].

作者信息

Bautin A E, Khubulava G G, Osovskikh V V, Rozenberg O A

出版信息

Anesteziol Reanimatol. 2003 Jul-Aug(4):55-7.

PMID:14524023
Abstract

The clinical course and outcomes of cases of acute respiratory distress syndrome (ARDS) as evolved after open-heart surgeries under the conditions of traditional treatment and under the conditions of using the exogenous surfactant drug were comparatively analyzed. A reliably improved oxygenation was registered in the 1st group patients (18 subjects), who received surfactant, yet 24 hours later; while the identical improvement was noted in the 2nd group patients (19 subjects) only in 98 hours. The possibility of respiratory support with FiO2 below 45% was ensured in 15 (83.3%) patients of group 1 and in 10 (52.6%) patients of group 2. Thirteen (72.2%) patients in the 1st group and 9 (47.4%) patients in the 2nd group were transferred to independent breathing. The lethality rate in ARDS with the surfactant therapy made up 33.3%, it was 52.6% in traditional treatment.

摘要

相似文献

1
[Natural surfactant preparation in complex therapy of acute respiratory distress syndrome in adults following open-heart surgeries].
Anesteziol Reanimatol. 2003 Jul-Aug(4):55-7.
2
[Surfactant-BL and inhaled nitric oxide in acute respiratory distress syndrome in cardiac surgical patients].[表面活性物质BL与吸入一氧化氮用于心脏手术患者急性呼吸窘迫综合征的治疗]
Anesteziol Reanimatol. 2005 Nov-Dec(6):38-41.
3
Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.外源性表面活性剂对心脏手术后急性呼吸窘迫综合征婴儿的有益作用。
Eur J Cardiothorac Surg. 2011 Sep;40(3):557-62. doi: 10.1016/j.ejcts.2011.01.008. Epub 2011 Mar 2.
4
Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome.基于重组表面活性蛋白C的表面活性剂对急性呼吸窘迫综合征的影响。
N Engl J Med. 2004 Aug 26;351(9):884-92. doi: 10.1056/NEJMoa033181.
5
Natural surfactant supplementation in ARDS in paediatric age.小儿急性呼吸窘迫综合征中的天然表面活性剂补充治疗
Minerva Anestesiol. 1999 May;65(5 Suppl 1):92-7.
6
A critical look at the surfactant therapy: when, how much, and what to use?对表面活性剂治疗的批判性审视:何时、用量多少以及使用何种表面活性剂?
Acta Anaesthesiol Scand Suppl. 1997;111:74-7.
7
Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.外源性天然表面活性剂治疗急性肺损伤和急性呼吸窘迫综合征。
Am J Respir Crit Care Med. 2009 Nov 15;180(10):989-94. doi: 10.1164/rccm.200812-1955OC. Epub 2009 Aug 27.
8
Animal models and clinical pilot studies of surfactant replacement in adult respiratory distress syndrome.
Eur Respir J Suppl. 1989 Mar;3:98s-103s.
9
The use of exogenous surfactant to treat patients with acute high-permeability lung edema.
Prog Clin Biol Res. 1989;308:791-6.
10
Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant.用于治疗呼吸窘迫综合征的外源性天然表面活性剂制剂之间的生化和药理学差异:不同成分在有效肺表面活性剂中的作用
Eur J Pharmacol. 2007 Jul 30;568(1-3):1-15. doi: 10.1016/j.ejphar.2007.04.035. Epub 2007 Apr 30.